Medindia

X

Reportlinker Adds Artificial Organs - Worldwide Market Challenges & Opportunities

Wednesday, December 2, 2009 General News J E 4
Advertisement


NEW YORK, Dec. 1 Reportlinker.com announces that a new market research report is available in its catalogue:

Artificial Organs - Worldwide Market Challenges & Opportunities

http://www.reportlinker.com/p0164217/Artificial-Organs---Worldwide-Market-Challenges--Opportunities.html

With decades of research and advances in technology, artificial organs have become the viable alternative to effectively address donor organ shortage problem. Besides sustaining life and minimizing disease burden, artificial organs have been playing a crucial role in enhancing patient's quality of life. Additionally, artificial organs are not only enhancing patient outcomes and accelerating recovery times, but also minimizing overall healthcare expenditure. However, only few implantable devices have been approved for clinical use, while several others are still in clinical trials awaiting approvals.

With increasing number of patients suffering from late-stage diseases, organ failure has been accounting for the largest chunk of worldwide medical spending. On the other hand, the rising success rate of transplantation has been dramatically fuelling organ failure patients to opt for artificial organs. However, as organ recipients continue to rise, patient population on the waiting list is also expanding. The imbalance between number of receivers and donor organs has compelled the healthcare sector to search for other alternatives.

These and other market data and trends are presented in "Artificial Organs: Worldwide Market Challenges & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

ARTIFICIAL ORGANS BMR-1017

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. INDUSTRY OVERVIEW 4

Artificial Organs Revolutionize Medical Technology Industry 4

Current and Future Analysis 4

Market Outlook 5

Opportunities Abound for Bioartificial Organs 6

Bionics to Play Crucial Role 6

Economic Situation Plays a Pivotal Role in ESRD Treatment

Accessibility 7

Growth Drivers 7

Growth Inhibitors 8

3. MARKET TRENDS AND ISSUES 9

Higher Development Costs and Lengthy Regulatory Process -

Stumbling Blocks- for Product Commercialization 9

Lack of Requisite Expertise - Hindering Implantation Process 9

Alliances to Play a Key Role 10

Aging Population - A Boosting Factor 10

Anemia - A Growing Concern among Renal Failure Patients 10

Swelling ESRD Patient Population Spurs Dialyzers Growth 10

Growing Need for Efficient Control and Easy Usage 11

Expiry of Warranty Provides New Opportunities 11

Xenotransplantation - Other Alternative to Donor Organ Shortage 11

Artificial Organs from Cloned Animal Cells - A Promising Trend 11

Immunosuppressants Hold Promise in Artificial Organs Market 12

Move Towards Smaller Implantable Devices 12

Barriers to Entry Significantly High in Dialyzers Market 12

Reuse of Dialyzers - A Major Issue in Dialysis Industry 12

Poor Reimbursement Environment Stymies Innovation 13

Pricing Trends in Artificial Organs 13

4. COMPETITIVE SCENARIO 14

Competition Heating Up in Artificial Pancreas Domain 14

Fresenius Medical Care - Leads the Worldwide Dialysis

Equipment and Supplies- Market 15

Competitive Landscape of Artificial Kidney or Dialyzers Market 16

Synthetic Dialyzers to Attain Mainstay 16

Asahi Kasei Medical Dominates Japanese Dialyzers Market 17

Competitive Landscape of Ventricular Assist Devices 18

Liver Assist Devices Competitive Landscape 18

5. PRODUCT FACTS 19

Artificial Organs 19

Artificial Heart 20

Artificial Kidneys 20

Artificial Liver 20

Artificial Pancreas 20

Artificial Lungs 20

Organ Rejection - A Major Barrier to Transplantation 21

Other Issues for Organ Transplantation 21

Combined Organ Transplantation - Gaining Attention 21

6. REGULATORY ENVIRONMENT 22

Regulatory Environment in the US 22

Regulatory Environment in Europe 23

7. CORPORATE DEVELOPMENTS 24

Thoratec Receives FDA Approval for HeartMate II® 24

Asahi Kasei Institutes a Sales Subsidiary in Taiwan 24

Arbios Seeks CE Marking for SEPET(TM) 25

Gambro Teams up with Debiotech for Developing Peritoneal

Dialysis Cycler 25

Arbios Obtains US FDA Approval for Initiating Clinical Trial

for SEPET(TM) 25

Abiomed Obtains HDE Supplement Approval from FDA for AbioCor

®- Implantable Artificial Heart 25

Ventracor Obtains CE Marking for VentrAssist(TM) LVAD 26

Fresenius Medical Care Takes Over Renal Solutions, Inc. 26

Arbios Inks Exclusive Agreement with NxStage for SEPET(TM) 26

WorldHeart Completes First Multi-Day Animal Study of

PediaFlow(TM) VAD 26

Xcorporeal Completes Merger with CT Holdings 27

Nikkiso Collaborates with Nipro for Overseas Launch of

Dialysis Systems 27

Ege University to Initiate Artificial Heart Project 27

Vascutek Buys Kohler Chemie's Heart Valve Business 27

NovaThera Partners with NovaLung to Develop Advanced

Artificial Lung 27

Aksys Quits Kidney Dialysis Machines Business 28

Twardowski Terminates License Agreement with Aksys 28

Asahi Kasei Medical Fortifies Competence in Artificial Kidney

Production 28

Fresenius Medical Care Enhances Dialyzer Output 28

HepaLife Appoints Stem Cell Systems for Bioreactor Development 28

Gambro Unveils AK 96(TM) Dialyzer 29

Nipro Introduces Artificial Kidney Dialyzer in Overseas Markets 29

University of Michigan Develops Artificial Lungs 29

USC Researchers Develop Argus II Retinal Prosthesis System for

Retinal Implant 29

Researchers Develop Cell Manipulation Technique for Organ

Regeneration- Process 30

Terumo to Introduce First CE Mark LVAS in Europe 30

Advanced Technique for Nerve Re-Growth Developed 30

8. MAJOR PLAYERS 31

Abbott Diabetes Care (USA) 31

Abiomed, Inc. (USA) 31

Arbios Systems, Inc. (USA) 31

Asahi Kasei Kuraray Medical Co., Ltd (Japan) 31

Baxter International, Inc. (USA) 32

F.Hoffmann-La Roche Ltd. (Switzerland) 32

Fresenius Medical Care AG & Co. KgaA (Germany) 32

Fresenius Medical Care North America Inc (USA) 32

Fresenius Kawasumi (Japan) 32

Gambro AB (Sweden) 33

Hepalife Technologies, Inc. (USA) 33

Jarvik Heart, Inc. (USA) 33

MC3, Inc. (USA) 33

Medtronic, Inc. (USA) 33

MicroMed Cardiovascular, Inc. (USA) 33

Nikkiso Co., Ltd. (Japan) 34

Nipro Corporation (Japan) 34

SynCardia Systems, Inc. (USA) 34

Terumo Corporation (Japan) 34

Thoratec Corporation (USA) 35

Toray Medical Co., Ltd. (Japan) 35

Ventracor Limited (Australia) 35

Vital Therapies, Inc. (USA) 35

WorldHeart Corporation (USA) 35

9. GLOBAL MARKET ANALYTICS 36

EXHIBITS

Table 1: Percentage Breakdown of Leading Players in the

Worldwide Dialysis Equipment and Supplies Market by Sales-

2006

Table 2: Percentage Breakdown of Leading Players in the

Worldwide Hemodialysis Equipment and Supplies Market by Sales

- 2006

Table 3: Percentage Breakdown of Leading Players in the

Worldwide Peritoneal Dialysis Equipment and Supplies Market by

Sales - 2006

Table 4: Percentage Breakdown of Leading Players in the

Worldwide Dialyzers Market by Unit Output - 2007

Table 5: Percentage Breakdown of Leading Players in the

Japanese Kidney Dialyzers Market by Sales - 2006

Table 6: Percentage Breakdown of Leading Players in the

Worldwide VADs Market by Sales - 2006

Table 7: Global Artificial Organs Market by Product Segment

for the Period 2007-2015 (Sales in US$ Million)

Table 8: Percentage Breakdown of Global Artificial Organs

Market by Product Segment for the Years 2008 & 2012

Table 9: Global Artificial Kidneys/Dialyzers Market by Region

for the Period 2007-2015 (Sales in US$ Million)

Table 10: Percentage Breakdown of Global Artificial

Kidneys/Dialyzers Market by Region for the Years 2008 & 2012

Table 11: Global Insulin Pumps (External) Market by Region for

the Period 2007-2015 (Sales in US$ Million)

Table 12: Percentage Breakdown of Global Insulin Pumps

(External) Market by Region for the Years 2008 & 2012

COMPANIES PROFILED

To order this report:

Medical Equipment and Supply Industry: Artificial Organs - Worldwide Market Challenges & Opportunities

More Market Research Report

Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds Medical Waste Management - US Ma...
S
drugstore.com, inc. Has Best Day Ever on Cyber Mon...